Today: 17 April 2026
Blue Owl stock slips again as SEC filings and private-credit redemptions keep investors jumpy
4 March 2026
2 mins read

Blue Owl stock slips again as SEC filings and private-credit redemptions keep investors jumpy

New York, March 4, 2026, 08:09 EST

  • Blue Owl shares dropped below the $10 listing price this Tuesday, hit by worries swirling around private credit.
  • An internal move of shares and operating units by a major holder surfaced in a recent Form 4 filing.
  • A Rule 144 filing pointed to plans for a multi-million share sale of Class A stock

Blue Owl Capital (OWL.N) struggled again Wednesday, remaining below the $10 listing line after dipping under it the previous session. Liquidity concerns in private-credit funds linger, and new insider filings haven’t helped sentiment. Shares pointed lower, off roughly 3.8% at $10.27.

These shifts are drawing attention as private credit faces its first real crunch from surging redemption demands—cash that retail-style funds say investors can take out, even if the loans themselves aren’t exactly liquid. Blackstone’s $82 billion BCRED, for instance, disclosed Monday it tapped both employee and firm money to stay under its redemption limits. Meanwhile, a Reuters Breakingviews piece pointed out that Blue Owl, a rival, had “recently suspended withdrawals” from one of its smaller funds. Reuters

Blue Owl has become something of a stand-in for this trade. Its public and private lending funds are designed for reliable income, but the conversation has shifted. Investors are sizing up how Blue Owl manages exits—and what those loan portfolios might fetch if forced selling ramps up.

Last month, Blue Owl responded to speculation about restricted withdrawals, denying any freeze on investor cash. “We are not halting investor liquidity in” Blue Owl Capital Corp II, the company said. Blue Owl had swapped out its usual quarterly redemption program for direct payouts, committing to return 30% of the fund’s net asset value to investors. Reuters

Just two days on, fresh scrutiny hit the company when word got out about a $1.4 billion loan sale and who exactly was on the buyer list, with sector peers also sliding lower. “A lot of pushback this morning” centered on Blue Owl’s insurance arm taking part in the purchase, according to Brian Finneran, managing director at Truist Financial, in comments to Reuters. Blue Owl co-president Craig Packer pushed back, saying the move was procedural, not a wind-down: “We think this is a difficult short-term patch. Our results are good over time.” Reuters

Monday brought fresh data for traders eyeing flows and valuations, as a new SEC filing landed. Dyal Capital SLP LP reported moving 150,000 Class D shares and another 150,000 Blue Owl operating group units to certain limited partners, and, notably, the transfer was “for no consideration,” according to a Form 4 filing. SEC

The document called it a reallocation, not an open-market sale, and showed the holder retained indirect control of over 133 million Class D shares—plus an equal count of operating units—after the transfer.

A different filing hinted at possible selling, at least on paper. According to a Rule 144 notice dated March 2, roughly 5.83 million Class A common shares were set for sale via J.P. Morgan Securities LLC, with the shares listed on the NYSE, a portion of the filing indicated.

The rout in Blue Owl has, at points, dragged down peers—particularly other alternative managers running sizable private-credit operations. Investors are left weighing the pace of loan repayments and questioning if funds could be forced to unload assets into softening markets.

Blue Owl, along with the rest of the sector, faces a straightforward risk: a pickup in redemptions and tender requests, combined with shrinking loan market liquidity, could force managers to sell assets at less favorable prices or clamp down on withdrawals—potentially sapping confidence further. Both outcomes can turn self-reinforcing.

Stock Market Today

  • Analysts Adjust Sage Group Valuations Amid Mixed Execution Views
    April 16, 2026, 11:05 PM EDT. Sage Group (LSE:SGE) sees a recalibration of analyst price targets, with valuations cut from around £13 to about £11.40, reflecting tweaks to growth assumptions rather than a fundamental shift in outlook. Citi retains a Buy rating despite lowering its price target to £11.50 from £14.00, signaling continued upside potential. Meanwhile, JPMorgan and others show increased caution, trimming targets as they reassess growth and execution risks. Strategic partnerships, including with Barclays, SumUp, and HSBC UK, leverage Sage technology to enhance financial tools for small UK businesses, aligning with upcoming tax digitalisation deadlines. These integrations may support Sage's long-term growth despite immediate valuation pressures. Investors are encouraged to monitor analyst updates and market reactions as the narrative around Sage evolves amid these mixed signals.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks
Previous Story

FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks

Venture Global shares jump after New York judge blocks Shell bid in LNG fight
Next Story

Venture Global shares jump after New York judge blocks Shell bid in LNG fight

Go toTop